Skip to main content

Table 1 Demographic data of studied groups

From: Effect of long-term administration of clonazepam, carbamazepine, and valproate on cognitive, psychological, and personality changes in adult epilepsy: a case–control study

Variables Group 1
N = 35
N (%)
Group 2
N=18
N (%)
Group 3
N = 31
N (%)
Group 4
N = 15
N (%)
Group 5
N = 40
N (%)
P value
Age (mean ±SE) 41.86 ± 12.56 27.83 ± 6.32 37.35 ± 8.63 34.80 ± 12.63 36.13 ± 11.13 0.002*
Sex
 Male 10 (28.6%) 15 (83.3%) 21 (67.7%) 6 (40%) 31 (51.5%) 0.001*
 Female 25 (71.4%) 3 (16.7%) 10 (32.3%) 9 (60%) 29 (48.3%)  
Marital status
 Single 8 (22.9%) 9 (50%) 11 (35.5%) 3 (20%) 20 (33.3%) 0.03*
 Married 25 (71.4%) 9 (50%) 18 (58%) 9 (60%) 38 (63.3%)  
 Divorce 0 (0%) 0 (0%) 2 (6.5%) 0 (0%) 0 (0%)  
 Widow 2 (5.7%) 0 (0%) 0 (0%) 3 (20%) 2 (3.3%)  
Education
 Illiterate 32 (91.4%) 6 (33.3%) 25 (80.6%) 9 (60%) 33 (55%) 0.000*
 Primary education 0 (0%) 0 (0%) 3 (9.7%) 0 (0%) 10 (16.7%)  
 High education 3 (8.6%) 12 (66.7%) 3 (9.7%) 6 (40%) 17 (28.3%)  
Occupation state
 Not working 28 (80%) 9 (50%) 17 (54.8%) 9 (60%) 33 (55%) 0.172
 Employers 7 (20%) 9 (50%) 14 (45.2%) 6 (40%) 27 (45%)  
  1. Group 1: carbamazepine, group 2: valproate, group 3: carbamazepine and clonazepam, group 4: valproate and clonazepam, group 5: epileptic patients without antiepileptic drugs (AEDs), *significant P value